NovoCure Limited Liabilities, Noncurrent
NovoCure Limited (NVCR) had Liabilities, Noncurrent of $236.39 million as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LiabilitiesNoncurrent · last filed 2026-07-23
- 2026-06-30: Liabilities, Noncurrent $236.39M.
- 2026-03-31: Liabilities, Noncurrent $239.63M.
- 2025-12-31: Liabilities, Noncurrent $240.63M.
- 2025-09-30: Liabilities, Noncurrent $243.85M.
| Period end | Liabilities, Noncurrent | Liabilities, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $236.39M 10-Q · filed 2026-07-23 | |
| 2026-03-31 | $239.63M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $240.63M 10-Q · filed 2026-07-23 | |
| 2025-09-30 | $243.85M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $146.80M 10-Q · filed 2025-07-24 | |
| 2025-03-31 | $143.55M 10-Q · filed 2025-04-24 | |
| 2024-12-31 | $124.21M 10-K · filed 2026-02-26 | $124.23M 10-K · filed 2025-02-27 |
| 2024-09-30 | $126.20M 10-Q · filed 2024-10-30 | |
| 2024-06-30 | $681.24M 10-Q · filed 2024-07-25 | |
| 2024-03-31 | $601.84M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $604.52M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $595.49M 10-Q · filed 2023-10-26 | |
| 2023-06-30 | $593.25M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $593.42M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $591.70M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $587.74M 10-Q · filed 2022-10-27 | |
| 2022-06-30 | $585.60M 10-Q · filed 2022-07-28 | |
| 2022-03-31 | $586.53M 10-Q · filed 2022-04-28 | |
| 2021-12-31 | $586.40M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $582.74M 10-Q · filed 2021-10-28 | |
| 2021-06-30 | $583.58M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $585.01M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $461.85M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $28.68M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $176.00M 10-Q/A · filed 2020-10-02 | |
| 2020-03-31 | $176.30M 10-Q/A · filed 2020-10-02 | |
| 2019-12-31 | $175.35M 10-K · filed 2021-02-25 | |
| 2019-09-30 | $173.09M 10-Q · filed 2019-10-31 | |
| 2019-06-30 | $173.72M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $172.91M 10-Q · filed 2019-05-02 | |
| 2018-12-31 | $162.97M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $152.49M 10-Q · filed 2018-10-25 | |
| 2018-06-30 | $152.55M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $152.60M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $101.53M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $104.61M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $104.33M 10-Q · filed 2017-07-27 | |
| 2017-03-31 | $103.81M 10-Q · filed 2017-04-27 | |
| 2016-12-31 | $102.85M 10-K · filed 2018-02-22 | |
| 2016-09-30 | $103.14M 10-Q · filed 2016-11-02 | |
| 2016-06-30 | $29.25M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $29.16M 10-Q · filed 2016-05-10 | |
| 2015-12-31 | $27.89M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $26.64M 10-Q · filed 2015-10-27 | |
| 2014-12-31 | $2.33M 10-K · filed 2016-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |